Literature DB >> 12534592

Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin.

P Nuutinen1, R Riekki, M Parikka, T Salo, P Autio, J Risteli, A Oikarinen.   

Abstract

BACKGROUND: Glucocorticoids have been shown to downregulate collagen synthesis in human skin in vivo, thereby contributing to skin atrophy.
OBJECTIVES: To compare the effects of continuous and intermittent use of topical hydrocortisone on skin collagen synthesis and, furthermore, to elucidate the mechanism of collagen synthesis reduction induced by hydrocortisone.
METHODS: Collagen propeptides reflecting the synthesis rate of type I and III collagens were studied from suction blister fluids in nine healthy subjects after 3 weeks of continuous (twice daily) or intermittent (on three consecutive days weekly) topical hydrocortisone treatment and 2 weeks after the termination of treatment. Type I collagen mRNA was studied in the same subjects from skin biopsies by using in situ hybridization (ISH) after 3 weeks of treatment.
RESULTS: Three weeks of continuous treatment decreased the types I and III collagen propeptides in suction blister fluid by 89% and 82%, respectively, while intermittent treatment resulted in a corresponding decrease of 53% and 50%. ISH studies from skin biopsies showed type I collagen mRNA to be markedly reduced in fibroblasts after continuous and intermittent steroid treatment. After a 2-week drug-free interval, the synthesis rate was completely restored in both areas, and some subjects even showed upregulation of synthesis in previously steroid-treated skin.
CONCLUSIONS: Continuous hydrocortisone for 3 weeks markedly decreases collagen propeptides and corresponding mRNA in human skin. Intermittent hydrocortisone has a less marked effect on the collagen synthesis rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534592     DOI: 10.1046/j.1365-2133.2003.05018.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Is half strength of 0.05 % betamethasone valerate cream still effective in the treatment of phimosis in young children?

Authors:  Paiboon Sookpotarom; Chanchuree Asawutmangkul; Benjaporn Srinithiwat; Sucheera Leethochawalit; Paisarn Vejchapipat
Journal:  Pediatr Surg Int       Date:  2013-04       Impact factor: 1.827

2.  Stereoisomers of an Aryl Pyrazole Glucocorticoid Receptor Agonist Scaffold Elicit Differing Anti-inflammatory Responses.

Authors:  Ashley M Lato; Susan J Burke; Maggie P Ducote; Brandon J Kennedy; J Jason Collier; Shawn R Campagna
Journal:  ACS Med Chem Lett       Date:  2022-08-22       Impact factor: 4.632

3.  Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist.

Authors:  Balsam El Ghoul; Tarek Squalli; Aude Servais; Caroline Elie; Vannary Meas-Yedid; Christine Trivint; Jill Vanmassenhove; Jean-Pierre Grünfeld; Jean-Christophe Olivo-Marin; Eric Thervet; Laure-Hélène Noël; Dominique Prié; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

4.  11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.

Authors:  Ana Tiganescu; Abd A Tahrani; Stuart A Morgan; Marcela Otranto; Alexis Desmoulière; Lianne Abrahams; Zaki Hassan-Smith; Elizabeth A Walker; Elizabeth H Rabbitt; Mark S Cooper; Kurt Amrein; Gareth G Lavery; Paul M Stewart
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

5.  β-Ionone Attenuates Dexamethasone-Induced Suppression of Collagen and Hyaluronic Acid Synthesis in Human Dermal Fibroblasts.

Authors:  Dabin Choi; Wesuk Kang; Soyoon Park; Bomin Son; Taesun Park
Journal:  Biomolecules       Date:  2021-04-21

Review 6.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

Review 7.  Proline-dependent regulation of collagen metabolism.

Authors:  Ewa Karna; Lukasz Szoka; Thi Yen Ly Huynh; Jerzy A Palka
Journal:  Cell Mol Life Sci       Date:  2019-11-18       Impact factor: 9.261

8.  The Optimal Application of Medium Potency Topical Corticosteroids in Preventing Laser-Induced Inflammatory Responses-An Animal Study.

Authors:  Kuang-Ling Ou; Chia-Cheng Wen; Ching-Ya Lan; Yu-An Chen; Chih-Hsin Wang; Yi-Wen Wang
Journal:  Life (Basel)       Date:  2021-04-17

9.  Effect of Vitamin C/Hydrocortisone Immobilization within Curdlan-Based Wound Dressings on In Vitro Cellular Response in Context of the Management of Chronic and Burn Wounds.

Authors:  Michal Wojcik; Paulina Kazimierczak; Vladyslav Vivcharenko; Malgorzata Koziol; Agata Przekora
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

10.  Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.

Authors:  R A Ajjan; E M A Hensor; F Del Galdo; K Shams; A Abbas; R J Fairclough; L Webber; L Pegg; A Freeman; A E Taylor; W Arlt; A W Morgan; A A Tahrani; P M Stewart; D A Russell; A Tiganescu
Journal:  Eur J Endocrinol       Date:  2022-02-28       Impact factor: 6.664

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.